April 13, 2021
1,086
12
19
2.85%
Every word spoken in this episode is indexed. Type any phrase to jump straight to the moment it was said.
Type any word or phrase that may have been spoken. Click a result to seek the player to that exact moment.
Try a name, a topic, or a quoted line
1:30Now PlayingThe U.S. expects it will have enough coronavirus vaccine to meet U.S. demand by May despite a pause in the use of Johnson & Johnson’s shot, an official familiar with the matter said.
Production from Pfizer Inc. and Moderna Inc. should be enough to meet U.S. demand, one official said, speaking on condition of anonymity, as signs emerge that the U.S. is beginning to shift from a shortage of shots to a shortage of willing recipients.
Pfizer and Moderna make up about 95% of weekly U.S. shots being allocated as of now, with J&J accounting for the rest. President Joe Biden has pledged to have enough vaccine, including J&J, for all Americans by the end of May, but it’s not clear how many Americans want the shot.
It’s not clear how long the pause will last, and use of the J&J shot could resume. The U.S. Expects to receive 24 million doses from the company this month.
Subscribe to our YouTube channel
Bloomberg Quicktake brings you live global news and original shows spanning business, technology, politics and culture. Make sense of the stories changing your business and your world.
To watch complete coverage on Bloomberg Quicktake 24/7, visit or watch on Apple TV, Roku, Samsung Smart TV, Fire TV and Android TV on the Bloomberg app.
Have a story to tell? Fill out this survey for a chance to have it featured on Bloomberg Quicktake
Connect with us on…
Breaking News on YouTube
Sentinel Indexing in Progress
Metadata and chapters are available. Claim extraction for this episode is pending.
All video content is delivered via YouTube embedded players in accordance with the YouTube Terms of Service. Sentinel provides research tools that promote discovery and accountability across political media.